Cancer‐Associated ThrOmboSIs – Patient‐Reported OutcoMes With RivarOxaban (COSIMO) – Baseline characteristics and clinical outcomes

BACKGROUND: Patients with cancer‐associated thrombosis (CAT) have a high risk of recurrent venous thromboembolic events, which contribute to significant morbidity and mortality. Direct oral anticoagulants may provide a convenient treatment option for these patients. OBJECTIVES: To assess clinical ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Maraveyas, Anthony, Beyer‐Westendorf, Jan, Lee, Agnes Y., Mantovani, Lorenzo G., De Sanctis, Yoriko, Abdelgawwad, Khaled, Fatoba, Samuel, Bach, Miriam, Cohen, Alexander T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633229/
https://www.ncbi.nlm.nih.gov/pubmed/34877446
http://dx.doi.org/10.1002/rth2.12604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633229/
https://www.ncbi.nlm.nih.gov/pubmed/34877446
http://dx.doi.org/10.1002/rth2.12604

Ejemplares similares